Salphen-Based Fe-N2O2@C Nanomaterial Applied in Synergistic Sonodynamic and Chemodynamic Therapy of Tumors

RONG Xiao, LI Zhexuan, ZUO Yan, QIU Li

Abstract

To synthesize a Salphen-based Fe-N2O2@C material with high peroxidase (POD)-mimicking activity and sonosensitivity for the synergistic sonodynamic (SDT) and chemodynamic (CDT) therapy of tumors.
Methods Fe-N2O2 was synthesized via the hydrothermal method, and Fe-N2O2@C was prepared by incorporating a ketjen black substrate. The morphology, structure, composition, enzyme mimic activity for reactive oxygen species (ROS) production, and sonosensitivity of the material were characterized. The ability and mechanism of Fe-N2O2@C to perform synergistic SDT and CDT killing of 4T1 mouse breast cancer cells were explored through in vitro experiments. The in vivo tumor-killing ability of Fe-N2O2@C combined with ultrasound irradiation was investigated using a subcutaneous 4T1 tumor-bearing mouse model.
Results FFe-N2O2 and Fe-N2O2@C were both irregularly shaped nanospheres with average particle sizes of 25.9 nm and 36.2 nm, respectively. XRD, FTIR, and XPS analyses confirmed that both Fe-N2O2 and Fe-N2O2@C possessed a Salphen covalent organic framework structure with M-N2O2 coordination, and the ketjen black loading had no significant impact on this structure. Compared to Fe-N2O2, Fe-N2O2@C exhibited high POD-mimicking activity (with Km reduced from 19.32 to 5.82 mmol/L and vmax increased from 2.51×10−8 to 8.92×10−8 mol/[L·s]) and sonosensitivity. Fe-N2O2@C in combination with ultrasound irradiation could produce a large amount of ROS within cells and a subsequent significant decrease in mitochondrial membrane potential, thereby inducing TEM-observable mitochondrial damage and causing cell apoptosis and death. In addition, in vivo experiments showed that Fe-N2O2@C in combination with ultrasound irradiation could effectively inhibit tumor growth in a 4T1 subcutaneous tumor-bearing mouse model without significant in vivo toxicity.
Conclusion In this study, we prepared a Salphen-based Fe-N2O2@C material with good biocompatibility, which can be used in combination with ultrasound irradiation to achieve SDT and CDT synergistic killing of tumor cells and inhibit tumor growth. This Salphen-based Fe-N2O2@C nanomaterial shows promising potential for multimodal tumor therapy.

 

Keywords: Covalent organic framework, Tumor killing, Enzyme mimetic materials, Chemodynamic therapy, Sonodynamic therapy

 

Full Text:

PDF


References


SONG X, LIU C, WANG N, et al. Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy. Adv Drug Deliv Rev, 2021, 168: 158–180. doi: 10.1016/j.addr.2020.04.010.

KOLARIKOVA M, HOSIKOVA B, DILENKO H, et al. Photodynamic therapy: innovative approaches for antibacterial and anticancer treatments. Med Res Rev, 2023, 43(4): 717–774. doi: 10.1002/med.21935.

SONG X, ZHANG Q, CHANG M, et al. Nanomedicine-enabled sonomechanical, sonopiezoelectric, sonodynamic, and sonothermal therapy. Adv Mater, 2023, 35(31): e2212259. doi: 10.1002/adma. 202212259.

PERI A, SALOMON N, WOLF Y, et al. The landscape of T cell antigens for cancer immunotherapy. Nat Cancer, 2023, 4(7): 937–954. doi: 10. 1038/s43018-023-00588-x.

FAN W, YUNG B, HUANG P, et al. Nanotechnology for multimodal synergistic cancer therapy. Chem Rev, 2017, 117(22): 13566–13638. doi: 10.1021/acs.chemrev.7b00258.

UTHAMAN S, HUH K M, PARK I K. Tumor microenvironment-responsive nanoparticles for cancer theragnostic applications. Biomater Res, 2018, 22: 22. doi: 10.1186/s40824-018-0132-z.

DU F, LIU L, WU Z, et al. Pd-single-atom coordinated biocatalysts for chem-/sono-/photo-trimodal tumor therapies. Adv Mater, 2021, 33(29): e2101095. doi: 10.1002/adma.202101095.

XIANG X, PANG H, MA T, et al. Ultrasound targeted microbubble destruction combined with Fe-MOF based bio-/enzyme-mimics nanoparticles for treating of cancer. J Nanobiotechnology, 2021, 19(1): 92. doi: 10.1186/s12951-021-00835-2.

FENG Z, XIANG X, HUANG J, et al. Intelligent Sonocatalytic nanoagents for energy conversion-based therapies. Advanced Functional Materials, 2023, 33(45): 2302579. doi: 10.1002/adfm.202302579.

ZHANG H, LIU X, LIU Y, et al. Effect of hematoporphyrin monomethyl ether-sonodynamic therapy (HMME-SDT) on hypertrophic scarring. PLoS One, 2014, 9(1): e86003. doi: 10.1371/journal.pone.0086003.

ZIENTAL D, CZARCZYNSKA-GOSLINSKA B, MLYNARCZYK D T, et al. Titanium dioxide nanoparticles: prospects and applications in medicine. Nanomaterials (Basel), 2020, 10(2):387. doi: 10.3390/nano10020387.

ALIZADEH N, SALIMI A. Multienzymes activity of metals and metal oxide nanomaterials: applications from biotechnology to medicine and environmental engineering. J Nanobiotechnol, 2021, 19(1): 26. doi: 10. 1186/s12951-021-00771-1.

VELÁSQUEZ-HERNÁNDEZ M D J, RICCO R, CARRARO F, et al. Degradation of ZIF-8 in phosphate buffered saline media. CrystEngComm, 2019, 21(31): 4538–4544. doi: 10.1039/C9CE00757A.

KHAN N, SLATHIA G, KALIYA K, et al. Recent progress in covalent organic frameworks for cancer therapy. Drug Discov Today, 2023, 28(6): 103602. doi: 10.1016/j.drudis.2023.103602.

GAUR A, SHRIVASTAVA B, SRIVASTAVA K, et al. XAFS investigations of copper (Ⅱ) complexes with tetradentate schiff base ligands. X‐Ray Spectrometry, 2012, 41(6): 384–392. doi: 10.1002/xrs.2418.

YAN S, GUAN X, LI H, et al. Three-dimensional Salphen-based covalent-organic frameworks as catalytic antioxidants. J Am Chem Soc, 2019, 141(7): 2920–2924. doi: 10.1021/jacs.9b00485.


Refbacks

  • There are currently no refbacks.